REGISTERED
on 05 Dec 2023
Last Applicant/ Owned by
7820 Palace Drive
Cincinnati
OH
45249
Serial Number
88649091 filed on 10th Oct 2019
Registration Number
7236721 registered on 05th Dec 2023
Correspondent Address
Carrie A. Johnson
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
KEYPHARMA
Pharmaceuticals for pain management; pharmaceuticals for the treatment of allergies; pharmaceuticals for the treatment and prevention of digestive, cardiovascular, immune system, urology, central nervous system, respiratory, bone, eye, ear, nose throat, dermatological, ophthalmological, endocrine, musculo-skeletal, obstetric and gynecological, urinary and gastrointestinal diseases, infections, and Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceuticals for pain management; pharmaceuticals for the treatment of allergies; pharmaceuticals for the treatment and prevention of digestive, cardiovascular, immune system, urology, central nervous system, respiratory, bone, eye, ear, nose throat, dermatological, ophthalmological, endocrine, musculo-skeletal, obstetric and gynecological, urinary and gastrointestinal diseases, infections, and conditions; nutritional and dietary supplements
First Use Date in General
09th Aug 2023
First Use Date in Commerce
09th Aug 2023
Mark Details
Serial Number
No 88649091
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 219561
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 05th Dec 2023 | REGISTERED-PRINCIPAL REGISTER |
| 05th Dec 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 01st Nov 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 31st Oct 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 19th Aug 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| 15th Aug 2023 | TEAS STATEMENT OF USE RECEIVED |
| 15th Aug 2023 | USE AMENDMENT FILED |
| 20th Jan 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 19th Jan 2023 | SOU EXTENSION 5 GRANTED |
| 17th Jan 2023 | SOU TEAS EXTENSION RECEIVED |